BioNTech Cash from Financing (TTM) Trends

BioNTech SE (BNTX)

91.73 -0.28 (-0.30%) USD | NASDAQ | May 10, 16:00

91.73 0.00 (0.00%) After-Hours: 18:58

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	-538.52M
December 31, 2023	-842.92M
September 30, 2023	-965.88M
June 30, 2023	-1.246B
March 31, 2023	-1.900B
December 31, 2022	-1.497B
September 30, 2022	-1.422B
June 30, 2022	-814.29M
March 31, 2022	206.98M

Date	Value
December 31, 2021	111.46M
September 30, 2021	280.23M
June 30, 2021	1.037B
March 31, 2021	1.014B
December 31, 2020	1.022B
September 30, 2020	1.057B
June 30, 2020	586.79M
March 31, 2020	430.22M
December 31, 2019	429.10M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.900B

Minimum

Mar 2023

1.057B

Maximum

Sep 2020

-169.47M

Average

159.22M

Median

Cash from Financing (TTM) Benchmarks